<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Congenital contractural <z:hpo ids='HP_0001166'>arachnodactyly</z:hpo> (CCA) is caused by mutations in the gene for fibrillin 2 glycoprotein, a component of connective tissue </plain></SENT>
<SENT sid="1" pm="."><plain>The causes of <z:e sem="disease" ids="C0264009" disease_type="Disease or Syndrome" abbrv="">osteodystrophy</z:e> or osteodysplasia in CCA are unknown </plain></SENT>
<SENT sid="2" pm="."><plain>We report bone metabolism in a 28 month-old girl with CCA </plain></SENT>
<SENT sid="3" pm="."><plain>Serum alkaline phosphatase and osteocalcin levels were 650 IU/l and 22 ng/ml at 1.5 months old (control: 530+/-65, 16.5+/-4.3), and 580 IU/l and 21 ng/ml at 28 months old (control: 465+/-58, 15.0+/-3.5), i.e. in upper-<z:mpath ids='MPATH_458'>normal</z:mpath> levels </plain></SENT>
<SENT sid="4" pm="."><plain>The urinary pyridinoline and deoxypyridinoline levels were 1176 and 194 micromol/mol <z:chebi fb="0" ids="16737">creatinine</z:chebi> at 1.5 months old (control: 329+/-76, 63+/-12), and 407 and 111 micromol/mol cr at 28 months old (control: 231+/-49, 50+/-11), apparently higher than the control values </plain></SENT>
<SENT sid="5" pm="."><plain>These findings may indicate that abnormal fibrillin may impair bone metabolism and cause the <z:e sem="disease" ids="C0264009" disease_type="Disease or Syndrome" abbrv="">osteodystrophy</z:e> or osteodysplasia in CCA </plain></SENT>
</text></document>